Publications by authors named "E Mylona"

Article Synopsis
  • This study investigates how different feature selection methods, machine learning classifiers, and radiomic feature sources influence the accuracy of models predicting clinically significant prostate cancer from MRI data.
  • Two datasets containing 465 and 204 patients allowed for the extraction of 1246 radiomic features, and 480 models were evaluated using various metrics, with the best-performing models leveraging specific feature selection methods and classifiers.
  • The findings highlight the importance of selecting the right feature selection method and source of radiomic features, as they significantly impact model performance for diagnosing prostate cancer.
View Article and Find Full Text PDF

Systematic surveillance of infection (CDI) in our institution showed a reduction in the incidence of healthcare associated CDI (HA-CDI) during COVID-19 pandemic. Our objective was to search for factors related to this reduction. We retrospectively studied the trend of the incidences of HA-CDI, Multidrug Resistant (MDR) organisms, total antibiotic and chlorine consumptions as well as the influence of the last two on the incidence of HA-CDI.

View Article and Find Full Text PDF

Mentoring plays an integral role in the success of faculty. This study explores faculty access to formal and informal mentorship and how mentorship impacts faculty engagement. Data are from 2020 to 2023 administrations of the StandPoint Faculty Engagement Survey.

View Article and Find Full Text PDF

Enteric fever remains a major public health problem in South and Southeast Asia. The recent roll-out of the typhoid conjugate vaccine protecting against S. Typhi exhibits great promise for disease reduction in high burden areas.

View Article and Find Full Text PDF
Article Synopsis
  • Passive administration of the monoclonal antibody cocktail CAS + IMD showed positive clinical outcomes in hospitalized COVID-19 patients, particularly those who were seronegative at the start of treatment.
  • The study involved 46 patients and used advanced immunoprofiling techniques to assess how the antibody treatment influenced immune responses over time, from October 2020 to April 2021.
  • Results indicated that CAS + IMD not only reduced acute inflammation but also enhanced recovery without harming the host's T cell immune response, suggesting a beneficial anti-inflammatory effect that needs further exploration.
View Article and Find Full Text PDF